ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

CADL Candel Therapeutics Inc

9.4329
0.5829 (6.59%)
取引時間後
最終更新日: 06:58:26
15分遅延
名称 銘柄コード 市場 種別
Candel Therapeutics Inc CADL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.5829 6.59% 9.4329 06:58:26
始値 安値 高値 終値 前日終値
9.00 8.66 9.64 9.59 8.85
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2521:00GLOBECandel Therapeutics Announces Upcoming Presentations at the..
2024/4/1122:00GLOBECandel Therapeutics Receives FDA Orphan Drug Designation for..
2024/4/0921:00GLOBECandel Therapeutics Presents Preclinical Data at AACR on..
2024/4/0421:00GLOBECandel Therapeutics Announces Positive Interim Data from..
2024/3/2905:05GLOBECandel Therapeutics Announces Oral Presentation During the..
2024/3/2821:05GLOBECandel Therapeutics Reports Fourth Quarter and Full Year..
2024/3/0622:00EDGAR2Form 8-K - Current report
2024/3/0606:30GLOBECandel Therapeutics Announces an Upcoming Presentation at..
2024/2/1323:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1321:45EDGAR2Form 8-K - Current report
2024/2/1321:30GLOBECAN-3110 Receives FDA Fast Track Designation for Treatment..
2024/2/0522:00GLOBECandel Therapeutics Sets Path to Success: Recent..
2024/1/1922:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/1306:30EDGAR2Form 8-K - Current report
2024/1/0322:30EDGAR2Form 8-K - Current report
2023/12/1222:58DJNCandel Therapeutics Shares Soar After FDA Fast Track of..
2023/12/1222:30EDGAR2Form 8-K - Current report
2023/12/1222:00GLOBECandel Therapeutics Receives FDA Fast Track Designation for..
2023/12/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2906:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2906:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2906:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2823:00EDGAR2Form 8-K - Current report
2023/11/2823:00GLOBECandel Therapeutics Announces Restructuring to Prioritize..
2023/11/2207:00EDGAR2Form 8-K - Current report
2023/11/0922:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0922:16EDGAR2Form 8-K - Current report
2023/11/0922:00GLOBECandel Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0622:53EDGAR2Form 8-K - Current report
2023/11/0622:15EDGAR2Form 8-K - Current report
2023/11/0421:00GLOBECandel Therapeutics Presents Preclinical Data from its..
2023/11/0401:00GLOBECandel Therapeutics Announces Initial Positive Interim Data..
2023/10/1900:31EDGAR2Form 8-K - Current report
2023/10/1900:00GLOBECandel Therapeutics Announces Nature Publication Showing..
2023/9/2722:40GLOBECandel Therapeutics Announces Three Abstracts Accepted for..
2023/9/2621:30EDGAR2Form 8-K - Current report
2023/9/2621:00GLOBECandel Therapeutics Reports Encouraging Initial Survival..
2023/9/0621:00GLOBECandel Therapeutics to Participate in the H.C. Wainwright..
2023/8/1021:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1021:15EDGAR2Form 8-K - Current report
2023/8/1021:00GLOBECandel Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0221:00GLOBECandel Therapeutics to Participate in the Canaccord Genuity..
2023/6/2922:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2922:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2922:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2921:31EDGAR2Form 8-K - Current report
2023/6/1321:00GLOBECandel Therapeutics Announces It Expects to Report Topline..
2023/6/0821:00GLOBECandel Therapeutics Appoints Experienced Manufacturing..

最近閲覧した銘柄

Delayed Upgrade Clock